Neuland Laboratories Ltd

BSE: 524558

26

total announcements

NEULANDLAB.BO · 15 min delayed

Key Stats · Yahoo Finance · as of 29 Oct 2026

Market Cap

₹25,680 Cr

P/E (TTM)

51.0

P/E (Forward)

41.2

EPS (TTM)

₹392.40

52W Low

₹11,500.00

52W High

₹24,235.05

Dividend Yield

0.18%

Beta

0.28

Price / Book

13.7

Debt / Equity

16.1

Revenue (TTM)

₹2,372 Cr

Gross Margin

55.17%

Operating Margin

30.60%

BSEResultResults5 Aug 2026

Neuland Laboratories Ltd

Unaudited Financial Results of the Company for the quarter ended June 30, 2026

Neuland Laboratories Ltd has announced its unaudited financial results for the quarter ended June 30, 2026. The company has reported a corporate guarantee of Rs. 40 crores in favour of Gland Pharma Limited for establishing dedicated manufacturing capacity and incurring capital expenditure. Additionally, the company has enhanced its manufacturing capacity at Unit 1 located at Bonthapally Village, Gummadidala Mandal, Sangareddy District, Telangana.

Read more →📎 1 attachment
BSEBoard MeetingResults5 Aug 2026

Neuland Laboratories Ltd

Unaudited Financial Results of the Company for the quarter ended June 30, 2026

Neuland Laboratories Ltd has announced unaudited financial results for the quarter ended June 30, 2026, and approved a corporate guarantee of Rs. 40 crores in favour of Gland Pharma Limited for a loan licence agreement. The company also plans to enhance its manufacturing capacity at Unit 1 by 18 KL, with an investment of Rs. 39.8 crores.

Read more →📎 1 attachment
BSEAGM/EGMResults4 Aug 2026

Neuland Laboratories Ltd

Voting Results, Scrutinizer Report and proceedings of 42nd Annual General Meeting held on August 4, 2026

Neuland Laboratories Ltd held its 42nd Annual General Meeting on August 4, 2026, through video conferencing. The meeting was attended by 81 members, and the requisite quorum was present. The company declared a final dividend of Rs. 34.00 per equity share, and appointed a new director. The meeting was conducted in accordance with the circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India.

Read more →📎 1 attachment
BSECompany UpdateResults28 Jul 2026

Neuland Laboratories Ltd

Q1FY27 Earnings Call Intimation

Neuland Laboratories Ltd announces Q1FY27 Earnings Call details, inviting investors to a conference call on August 05, 2026, at 17:30 Hrs (IST). The company has been a leading manufacturer of APIs for over 4 decades, with cGMP certifications from various global authorities.

Read more →📎 1 attachment
← PreviousPage 2 of 2